Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Antidepressants Industry?
In the recent past, there has been a swift enlargement in the size of the peptide and oligonucleotide cdmo market. It is projected to increase from $2.16 billion in 2024 to $2.42 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. The expansion observed during the historical period can be linked to the escalating demand for therapeutic agents, improvements in synthesis and production, the emergence of personalized medicine, regulatory direction, as well as a heightened interest in antiviral peptides and mRNA vaccines underlining the importance of oligonucleotides in the creation of vaccines.
The market size for peptide and oligonucleotide cdmo is anticipated to experience swift expansion in the coming years, with an expected valuation of “$3.69 billion in 2029 with an 11.2% compound annual growth rate (CAGR). This projection of growth in the coming years is influenced by factors such as rising demand for custom-tailored medicine, advancements in the field of biotechnology, broadening applications, growing outsourcing trends, and an increasing prevalence of chronic illnesses. Key trends expected to shape the forecast period include tailored therapies, technological progress, challenges in quality management, worldwide expansion, and heightened partnerships among biopharmaceutical firms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15892&type=smp
#Which Factors Are Currently Driving The Growth Of The Antidepressants Market?
A worldwide increase in mental health issues is propelling the antidepressant drug market forward as numerous individuals depend on these pharmaceuticals to combat depression, anxiety disorders, and other mental illnesses. Antidepressant drugs are particularly useful in managing conditions such as depression, obsessive-compulsive disorder, major depressive disorder, severe anxiety disorder, bipolar disorder, post-traumatic stress disorder, childhood enuresis, and social anxiety disorder. The prevalence of depression globally ranges from 2% to 6%, with elderly individuals being at a higher risk compared to other demographics. A projection from WHO in 2023 estimated that roughly 280 million people worldwide were grappling with depression. Consequently, this surge in mental health ailments is predicted to fuel the expansion of the antidepressant market.
The peptide and oligonucleotide cdmo market covered in this report is segmented –
1) By Product: Peptides, Oligonucleotides
2) By Service Type: Contract Development, Contract Manufacturing,
3) By Application: Therapeutics, Research Applications, Diagnostics, Other Applications
4) By End User: Biopharmaceutical Companies, Pharmaceutical Companies, Research Institutes, Academic and Government Organizations, Others End Users
Subsegments:
1) By Peptides: Active Pharmaceutical Ingredients (Apis), Peptide Drug Products, Peptide Synthesis And Manufacturing Services
2) By Oligonucleotides: Antisense Oligonucleotides, Sirna And Mrna Oligonucleotides, Oligonucleotide Synthesis And Manufacturing Services
What Trends Are Currently Influencing Growth In The Antidepressants Market?
Leading companies in the peptide and oligonucleotide CDMO market are strategically partnering to improve their services, broaden their technical skills, and extend their market penetration. These partnerships in peptide development and production are mutual agreements between two entities concentrating on the creation and manufacturing of peptide-rooted therapeutics. Take for example, in May 2023, PolyPeptide Group AG, a US-based CDMO, formed a collaboration with Numaferm GmbH, a biotech firm from Germany, to focus on peptide development and production. The objective of this partnership is to leverage PolyPeptide’s cGMP manufacturing capacities and market presence, adding Numaferm’s proficiency in sustainable peptide manufacturing and biochemical production platforms. The collaboration aims to collectively investigate the formulation of suitable peptide candidates with a view towards a more environmentally friendly production of peptide-based APIs.
Who Are The Main Participants Shaping The Antidepressants Market Landscape?
Major companies operating in the peptide and oligonucleotide CDMO market are Thermo Fisher Scientific Inc., Merck KGaA, Ajinomoto Co. Inc., Lonza Group Ag, Wuxi Apptec Co. Ltd., Catalent Inc., Piramal Pharma Ltd., Curia Global Inc., Almac Group, Euroapi SA., CordenPharma International, Bachem Holding AG, Genscript Biotech Corporation, PolyPeptide Group, Rentschler Biopharma SE, Ambiopharm Inc., ScinoPharm, Senn Chemicals AG, Aurigene Pharmaceutical Services, Creative Peptides, Sylentis S.A.
Which Region Currently Holds The Largest Share In The Antidepressants Market?
North America was the largest region in the peptide and oligonucleotide CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide and oligonucleotide cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15892&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
